U.S. submits revised plea deal with Novelion's Aegerion to court

BOSTON (Reuters) - The U.S. Justice Department on Wednesday unveiled a revised a plea agreement with Aegerion Pharmaceuticals Inc that aimed to appease a federal judge who threatened to reject an earlier version that was part of a $36 million settlement.